Medical Research News

RSS

Researchers receive grant to evaluate efficacy of tobacco cessation methods

Researchers at The University of Kansas Cancer Center have received a five-year National Institutes of Health R0-1 grant to compare and evaluate the efficacy of optimized versus non-optimized tobacco cessation approaches for African American smokers.

27 Jun 2018

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

In preclinical experiments, Laurie Harrington, Ph.D., and colleagues at the University of Alabama at Birmingham have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease.

27 Jun 2018

New avenue for cancer treatment opens when one drug fails

A new class of cancer drugs – called CDK4/6 inhibitors -- recently approved to treat breast cancer can stunt the cancer's growth and replication.

27 Jun 2018

Research provides new target to help treat chemotherapy-induced diarrhea

Some 50 to 80 percent of cancer patients taking powerful chemotherapy drugs develop diarrhea, which can be severe and in some cases life-threatening.

27 Jun 2018

Injured athletes can benefit from using mindfulness

A new study of injured athletes carried out by the University of Kent found they can benefit from using mindfulness as part of the sport rehabilitation process to improve their pain tolerance and awareness.

27 Jun 2018

New approach needed to treat type 2 diabetes in youth

A major study has found that medicines used to treat diabetes in adults are not effective on youth. The researchers say the finding is disturbing because type 2 diabetes among youth is a growing problem.

27 Jun 2018

Polio virus could help brain cancer patients

According to researchers genetically altered poliovirus strains could help some patients of brain cancer. A team of researchers from Duke University in Durham, North Carolina, used modified polio virus strains in small groups of patients who had glioblastoma – a particularly deadly form of brain cancer. In these patients standard treatments have failed say the researchers and this novel therapy could help.

27 Jun 2018

Researchers develop new approach for studying Cryptosporidium in healthy human tissues

Washington State University researchers have developed a new approach for studying Cryptosporidium, a waterborne gastrointestinal parasite now recognized as one of the leading causes of potentially life-threatening diarrheal disease in young children worldwide.

26 Jun 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

Food insecurity in children associated with behavioral problems and poor cognitive outcomes

In 2016, 12.9 million children lived in food-insecure households. These children represent a vulnerable population since their developing brains can suffer long-term negative consequences from undernutrition and micronutrient deficiencies.

26 Jun 2018

AI could improve clinical diagnosis and treatment of prostate cancer

Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease.

26 Jun 2018

Many childhood cancer survivors show lack of concern for future well-being

A research team led by a St. Jude Children's Research Hospital epidemiologist has conducted the largest analysis to date of how adult survivors of childhood cancer view their health risk.

26 Jun 2018

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.

26 Jun 2018

Researchers examine new influenza drug's mode of action in detail

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.

26 Jun 2018

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.

26 Jun 2018

Researchers demonstrate feasibility of implanting micropacemaker in pericardial sac around the heart

Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart -- a breakthrough that may open up new cardiac pacing options for children and adults.

26 Jun 2018

New nuclear medicine approach shows potential for precision treatment of solid tumors

A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children.

26 Jun 2018

Are wearable defibrillators a suitable alternative to surgically implanted devices?

Wearable defibrillators may be a safe and effective alternative to surgically implanted devices among children with ventricular arrythmias that increase the risk of sudden cardiac death, according to a new study.

26 Jun 2018

Learning from nature's design of mosquito to create painless microneedles

A mosquito can insert a needle-like probe into your skin and draw blood for several minutes without you even noticing.

26 Jun 2018

Novel theranostic agent designed for precise tumor diagnosis and therapy

A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.

26 Jun 2018

Medical Research News

Researchers receive grant to evaluate efficacy of tobacco cessation methods

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

New avenue for cancer treatment opens when one drug fails

Research provides new target to help treat chemotherapy-induced diarrhea

Injured athletes can benefit from using mindfulness

New approach needed to treat type 2 diabetes in youth

Polio virus could help brain cancer patients

Researchers develop new approach for studying Cryptosporidium in healthy human tissues

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

Food insecurity in children associated with behavioral problems and poor cognitive outcomes

AI could improve clinical diagnosis and treatment of prostate cancer

Many childhood cancer survivors show lack of concern for future well-being

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

Researchers examine new influenza drug's mode of action in detail

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

Researchers demonstrate feasibility of implanting micropacemaker in pericardial sac around the heart

New nuclear medicine approach shows potential for precision treatment of solid tumors

Are wearable defibrillators a suitable alternative to surgically implanted devices?

Learning from nature's design of mosquito to create painless microneedles

Novel theranostic agent designed for precise tumor diagnosis and therapy

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News